PharmAthene, Inc. (PIP)


NYSE MKT - NYSE MKT Delayed Price. Currency in USD
2.86+0.01 (+0.35%)
At close: 4:01 PM EDT
People also watch:
SIGAPLXRNNOPXASNSS
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open2.86
Prev Close2.85
Bid2.65 x 1000
Ask4.45 x 10000
Day's Range2.83 - 2.88
52wk Range1.25 - 2.92
1y Target EstN/A
Market Cap187.59M
P/E Ratio (ttm)46.13
Beta2.09
Volume163,750
Avg Vol (3m)187,681
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • PR Newswire13 days ago

    PharmAthene Announces Receipt of Payments from SIGA

    ANNAPOLIS, Md., Sept. 16, 2016 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today announced it has received a series of payments ...

  • PR Newswirelast month

    PharmAthene Withdraws Protest Against HHS Over Anthrax Vaccine Bidding Process

    ANNAPOLIS, Md., Aug. 25, 2016 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today announced that after discussions with the ...

  • PR Newswire2 months ago

    PharmAthene Files Protest Against HHS Over Anthrax Vaccine Bidding Process

    ANNAPOLIS, Md., Aug. 5, 2016 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today filed a formal protest against the Department of Health and Human Services, challenging its solicitation for a next-generation Anthrax vaccine provider. According to the protest, filed with the U.S. Government Accountability Office, the government's "Request for Proposals" was written in a way that eliminates competition and assures a sole source award to Emergent BioSolutions Inc., the company that has long been the sole-source provider of the vaccine. The protest requests the GAO suspend the award under the solicitation while it reviews PharmAthene's complaint.